Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

The shortlist to run the Amazon-Berkshire-JPMorgan healthcare venture

As Berkshire Hathaway’s Warren Buffett has said, one of the first priorities for the highly anticipated healthcare venture between Berkshire, Amazon and JPMorgan is finding a CEO to run it. According to CNBC, two of the three names on their shortlist don’t want the job.

Thumbnail

HIMSS18: What providers have learned, what comes next for the Quality Payment Program

Clinicians have until March 31 to submit 2017 performance data for the Quality Payment Program established after passage of Medicare Access and CHIP Reauthorization Act (MACRA). HealthExec spoke with Beth Houck, MBA, the vice president of client services at value-based program compliance and analytics software company SA Ignite, at the HIMSS18 conference in Las Vegas.

Medical Group Management Association teaches practices how to be more profitable and transformative in patient care

High performing practices earn nearly $150,000 more in medical revenue, after operating costs, than other practices. In addition, optimized medical practice operations yield the highest quality care for patients. To help practices better their earning potential and increase patient outcomes, Medical Group Management Association (MGMA) will host MGMA18 | The Operations Conference on April 22-24 in Phoenix.

Thumbnail

CMS rejects Idaho’s plans to expand non-ACA-compliant insurance

Idaho’s plan to allow health insurers to offer coverage which doesn’t comply with the Affordable Care Act (ACA) would result in CMS fining insurance companies and taking over the state’s role in enforcing the law, essentially denying the state’s proposal to violate the ACA—but also offering the state some guidance on how it could approve the plans in the future.

Presence Health CEO resigns one week after Ascension acquisition

According to the Chicago Tribune, Presence president and CEO Michael Englehart told staff in a memo he “has decided to take some time off before pursuing new opportunities.” His last day will be March 30, ending a tenure with the company that began in October 2015.

Cigna to buy Express Scripts for $67B

Cigna announced this morning it will buy Express Scripts in a deal worth a total of $67 billion. The health insurer will assume $15 billion in debt from the pharmacy benefits manager (PBM) in addition to the $52 billion stock-and-cash transaction.

Thumbnail

Does the CMS push on data sharing mean the private sector failed on interoperability?

Health IT leaders, professionals and vendors saw few negatives in the new My HealthE Data initiative announced by CMS at the HIMSS18 conference in Las Vegas, even though CMS Administrator Seema Verma, MPH, warned that the agency would crack down on information blocking by vendors or providers.

Massachusetts officials give thumbs-up to Beth-Israel-Lahey merger

A potential merger of 13 hospitals in Massachusetts, led by Beth-Israel Deaconess Medical Center and Lahey Health, has been endorsed by state health officials, claiming it will improve services for patients.

Displaying 3737 - 3744 of 6654

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup